rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2002-2-21
|
pubmed:abstractText |
The prognosis of patients with germ cell tumours of the testis has Improved over the past two decades following cisplatinum-based chemotherapy. Currently, staging and risk assessment of the disease is crucial in order to provide curative therapy for patients with poor risk features and not over-treat good risk patients.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0970-258X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
18-21
|
pubmed:dateRevised |
2009-7-30
|
pubmed:meshHeading |
pubmed-meshheading:11855586-Adolescent,
pubmed-meshheading:11855586-Adult,
pubmed-meshheading:11855586-Aged,
pubmed-meshheading:11855586-Child,
pubmed-meshheading:11855586-Child, Preschool,
pubmed-meshheading:11855586-Germinoma,
pubmed-meshheading:11855586-Humans,
pubmed-meshheading:11855586-Infant,
pubmed-meshheading:11855586-Male,
pubmed-meshheading:11855586-Middle Aged,
pubmed-meshheading:11855586-Prognosis,
pubmed-meshheading:11855586-Retrospective Studies,
pubmed-meshheading:11855586-Testicular Neoplasms
|
pubmed:articleTitle |
Germ cell tumours of the testis: clinical features, treatment outcome and prognostic factors.
|
pubmed:affiliation |
All India Institute of Medical Sciences, New Delhi.
|
pubmed:publicationType |
Journal Article
|